Krsnaa Diagnostics · NSE: KRSNAA · BSE: 543328

Q2 FY23 results · Jul–Sep 2022

Krsnaa Diagnostics reported revenue from operations of ₹122.94 crore (up 13.6% from Q2 FY22) and net profit of ₹15.34 crore (up 22.4% from Q2 FY22) for Q2 FY23 (Jul–Sep 2022), on a consolidated basis.

Consolidated · ₹ crore
ItemQ2 FY23Q2 FY22YoYQ1 FY23QoQ
Revenue from operations122.94108.26+13.6%112.86+8.9%
Other income4.273.23+32.2%4.64−8.0%
Total income127.21111.49+14.1%117.50+8.3%
Profit before tax20.1616.62+21.3%18.68+7.9%
Net profit for the period15.3412.53+22.4%14.21+7.9%
EPS, basic (₹)5.734.51+27.1%4.53+26.5%
Net margin (%)12.511.612.6
Standalone · ₹ crore
ItemQ2 FY23Q2 FY22YoYQ1 FY23QoQ
Revenue from operations120.72108.26+11.5%111.77+8.0%
Other income4.273.23+32.3%4.65−8.1%
Total income124.99111.49+12.1%116.42+7.4%
Profit before tax23.6916.63+42.4%22.13+7.0%
Net profit for the period17.9712.54+43.3%16.80+7.0%
EPS, basic (₹)5.734.51+27.1%5.35+7.1%
Net margin (%)14.911.615.0
Consolidated
Filed with BSE
10 Nov 2022, 17:34 IST
Board meeting
09 Nov 2022
Period
01 Jul 2022 to 30 Sep 2022
Review status
Unaudited
Source
XBRL filing on BSE
Standalone
Filed with BSE
10 Nov 2022, 17:34 IST
Board meeting
09 Nov 2022
Period
01 Jul 2022 to 30 Sep 2022
Review status
Unaudited
Source
XBRL filing on BSE